Nivolumab and ipilimumab population pharmacokinetics in support of pediatric dose recommendations-Going beyond the body‐size effect

Abstract Body size has historically been considered the primary source of difference in the pharmacokinetics (PKs) of monoclonal antibodies (mAbs) between children aged greater than or equal to 2 years and adults. The contribution of age‐associated differences (e.g., ontogeny) beyond body‐size diffe...

Full description

Saved in:
Bibliographic Details
Main Authors: Zheyi Hu (Author), Sihang Liu (Author), Yue Zhao (Author), Shengnan Du (Author), Lora Hamuro (Author), Jun Shen (Author), Amit Roy (Author), Li Zhu (Author)
Format: Book
Published: Wiley, 2024-03-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available